BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 32512976)

  • 1. MicroRNA-196b promotes cell growth and metastasis of ovarian cancer by targeting ZMYND11.
    Zhang Z; Xu L; Hu Z; Yang B; Xu J
    Minerva Med; 2022 Aug; 113(4):707-717. PubMed ID: 32512976
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MicroRNA-1-3p inhibits the growth and metastasis of ovarian cancer cells by targeting DYNLT3.
    Zhu FJ; Li JZ; Wang LL
    Eur Rev Med Pharmacol Sci; 2020 Sep; 24(17):8713-8721. PubMed ID: 32964959
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Overexpression of microRNA-196b Accelerates Invasiveness of Cancer Cells in Recurrent Epithelial Ovarian Cancer Through Regulation of Homeobox A9.
    Chong GO; Jeon HS; Han HS; Son JW; Lee YH; Hong DG; Park HJ; Lee YS; Cho YL
    Cancer Genomics Proteomics; 2017; 14(2):137-141. PubMed ID: 28387653
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MicroRNA-200a promotes proliferation and invasion of ovarian cancer cells by targeting PTEN.
    Jiang JH; Lv QY; Yi YX; Liao J; Wang XW; Zhang W
    Eur Rev Med Pharmacol Sci; 2018 Oct; 22(19):6260-6267. PubMed ID: 30338796
    [TBL] [Abstract][Full Text] [Related]  

  • 5. DUXAP8 promotes the proliferation and migration of ovarian cancer cells via down-regulating microRNA-29a-3p expression.
    Li LM; Hao SJ; Ni M; Jin S; Tian YQ
    Eur Rev Med Pharmacol Sci; 2021 Feb; 25(4):1837-1844. PubMed ID: 33660793
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MiRNA-8073 targets ZnT1 to inhibit malignant progression of ovarian cancer.
    Zhang L; Wang YH; Wang L
    Eur Rev Med Pharmacol Sci; 2019 Jul; 23(14):6062-6069. PubMed ID: 31364107
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CircRNA UBAP2 promotes the progression of ovarian cancer by sponging microRNA-144.
    Sheng M; Wei N; Yang HY; Yan M; Zhao QX; Jing LJ
    Eur Rev Med Pharmacol Sci; 2019 Sep; 23(17):7283-7294. PubMed ID: 31539115
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lnc00908 promotes the development of ovarian cancer by regulating microRNA-495-5p.
    Jiang JN; Hong QY; Gao HJ; Lai BL; Lan JF; Yang Q
    Eur Rev Med Pharmacol Sci; 2019 Feb; 23(4):1388-1396. PubMed ID: 30840259
    [TBL] [Abstract][Full Text] [Related]  

  • 9. miRNA-217 inhibits proliferation of hepatocellular carcinoma cells by regulating KLF5.
    Gao W; Lu YX; Wang F; Sun J; Bian JX; Wu HY
    Eur Rev Med Pharmacol Sci; 2019 Sep; 23(18):7874-7883. PubMed ID: 31599412
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CCNB1, Negatively Regulated by miR-559, Promotes the Proliferation, Migration, and Invasion of Ovarian Carcinoma Cells.
    Yang X; Zhou S; Yang C; Cao C; He M; Zi S
    Mol Biotechnol; 2022 Sep; 64(9):958-969. PubMed ID: 35262876
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MicroRNA-129-5p inhibits invasiveness and metastasis of lung cancer cells and tumor angiogenesis via targeting VEGF.
    Cheng XK; Lin WR; Jiang H; Su ZH; Li L; Wang J
    Eur Rev Med Pharmacol Sci; 2019 Apr; 23(7):2827-2837. PubMed ID: 31002164
    [TBL] [Abstract][Full Text] [Related]  

  • 12. LncSNHG14 promotes ovarian cancer by targeting microRNA-125a-5p.
    Zhao YL; Huang YM
    Eur Rev Med Pharmacol Sci; 2019 Apr; 23(8):3235-3242. PubMed ID: 31081075
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MicroRNA-588 regulates migration capacity and invasiveness of renal cancer cells by targeting EIF5A2.
    Dong JS; Wu B; Zha ZL
    Eur Rev Med Pharmacol Sci; 2019 Dec; 23(23):10248-10256. PubMed ID: 31841179
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MiRNA-802 suppresses proliferation and migration of epithelial ovarian cancer cells by targeting YWHAZ.
    Yang B; Sun L; Liang L
    J Ovarian Res; 2019 Oct; 12(1):100. PubMed ID: 31640760
    [TBL] [Abstract][Full Text] [Related]  

  • 15. LncRNA SNHG7 promotes development of breast cancer by regulating microRNA-186.
    Luo X; Song Y; Tang L; Sun DH; Ji DG
    Eur Rev Med Pharmacol Sci; 2018 Nov; 22(22):7788-7797. PubMed ID: 30536320
    [TBL] [Abstract][Full Text] [Related]  

  • 16. LncRNA GIHCG promotes development of ovarian cancer by regulating microRNA-429.
    Yao N; Yu L; Zhu B; Gan HY; Guo BQ
    Eur Rev Med Pharmacol Sci; 2018 Dec; 22(23):8127-8134. PubMed ID: 30556850
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MicroRNA-196b promotes gastric cancer progression by targeting ECRG4.
    Chen L; Tang H; Liu G; Xiao S; Liang D; Ma J; Yang Y; Luo H; Zhu Y; Xie F; Cheng X; Chi J; Wu X
    Anticancer Drugs; 2021 Feb; 32(2):127-137. PubMed ID: 33417325
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MiR-539-3p promotes the progression of epithelial ovarian cancer by targeting SPARCL1.
    Gong YB; Fan XH
    Eur Rev Med Pharmacol Sci; 2019 Mar; 23(6):2366-2373. PubMed ID: 30964161
    [TBL] [Abstract][Full Text] [Related]  

  • 19. F-Box and Leucine-Rich Repeat Protein 20 (FBXL20), Negatively Regulated by microRNA (miR)-195-5p, Accelerates the Malignant Progression of Ovarian Cancer.
    Wu D; Liu C; Hong L
    Mol Biotechnol; 2021 Dec; 63(12):1235-1243. PubMed ID: 34338995
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MiRNA-584 suppresses the progression of ovarian cancer by negatively regulating LPIN1.
    Yang L; Ma HL
    Eur Rev Med Pharmacol Sci; 2020 Feb; 24(3):1062-1071. PubMed ID: 32096176
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.